Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results matching your filters

Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2Recruiting
NCT07263308Phase 3Updated Sep 9, 2026
Sponsor: Capital Medical University
Acute Ischemic Stroke
China
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)Recruiting
NCT07266831Phase 2, Phase 3Updated Sep 9, 2026
Sponsor: Merck Sharp & Dohme LLC
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
United States, Argentina, Canada, Chile, France +4 more
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque PsoriasisRecruiting
NCT07250802Phase 3Updated Sep 9, 2026
Sponsor: Takeda
Plaque Psoriasis
United States, China, Germany, Italy, Japan +2 more
Osimertinib With or Without Primary Lung Tumor Resection for EGFR-Mutant Oligometastatic Non-Small Cell Lung CancerRecruiting
NCT07738172Phase 3Updated Sep 9, 2026
Sponsor: National Taiwan University Hospital
Lung Neoplasms, Non-Small Cell Lung Cancer
Taiwan
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 DiabetesRecruiting
NCT07088068Phase 3Updated Sep 9, 2026
Sponsor: Sanofi
Type 1 Diabetes Mellitus
United States, Argentina, Australia, Belgium, Brazil +12 more
A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With AsthmaRecruiting
NCT06471257Phase 3Updated Sep 9, 2026
Sponsor: AstraZeneca
Asthma
China, Hong Kong
Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 TreatmentRecruiting
NCT07708727Phase 2, Phase 3Updated Sep 9, 2026
Sponsor: Gilead Sciences
HIV-1-infection
United States, Canada, Puerto Rico
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and OlderRecruiting
NCT07282665Phase 3Updated Sep 9, 2026
Sponsor: Pfizer
Clostridoides Difficile Associated Disease
United States, Argentina, Japan, United Kingdom
A Study to Evaluate the Mucosal Intestinal Immunity to Poliovirus Type-2 of nOPV2 at Birth Dose in Healthy IPV Vaccinated InfantsRecruiting
NCT07010822Phase 3Updated Sep 9, 2026
Sponsor: Fidec Corporation
Poliomyelitis
Bangladesh
A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)Recruiting
NCT05582993Phase 3Updated Sep 9, 2026
Sponsor: Takeda
Von Willebrand Disease (VWD)
United States, France, Ireland, Italy, Japan +1 more
Remibrutinib Open Label Roll-over Post-trial Access ProtocolRecruiting
NCT07456891Phase 3Updated Sep 9, 2026
Sponsor: Novartis Pharmaceuticals
Indication of the Parent Protocol
Bulgaria, Canada, Czechia, France, Poland +3 more
A Study to Evaluate Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)Recruiting
NCT07700056Phase 3Updated Sep 9, 2026
Sponsor: Novartis Pharmaceuticals
Chronic Pruritus of Unknown Origin
United States, Japan
CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for RecurrenceRecruiting
NCT06037980Phase 2, Phase 3Updated Sep 9, 2026
Sponsor: Gruppo Oncologico del Nord-Ovest
Biliary Tract Cancer · Cholangiocarcinoma
Italy
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)Recruiting
NCT05633654Phase 3Updated Sep 9, 2026
Sponsor: Gilead Sciences
Triple Negative Breast Cancer
United States, Australia, Belgium, Brazil, France +6 more
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic MedicinesRecruiting
NCT06671496Phase 3Updated Sep 9, 2026
Sponsor: Takeda
Psoriatic Arthritis
United States, Argentina, Australia, Brazil, Canada +7 more
Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell DiseaseRecruiting
NCT07274254Phase 3Updated Sep 9, 2026
Sponsor: Nantes University Hospital
Vaso-Occlusive Pain Episode in Sickle Cell Disease
France, Guadeloupe
An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer in ChinaRecruiting
NCT07604766Phase 3Updated Sep 9, 2026
Sponsor: Genmab
Platinum-resistant Ovarian Cancer
China
Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)Recruiting
NCT06711887Phase 3Updated Sep 9, 2026
Sponsor: Novartis Pharmaceuticals
Lupus Nephritis
United States, Brazil, China, Colombia, Czechia +13 more
A Clinical Study to Compare BupiZenge With Lidocaine for Pain Due to Oral Mucositis in Patients With Head and Neck Cancer.Recruiting
NCT07672236Phase 3Updated Sep 9, 2026
Sponsor: OncoZenge AB
Head & Neck Cancer · Oral Mucositis
Denmark, Germany, Norway, Sweden
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract CancerRecruiting
NCT04628767Phase 2, Phase 3Updated Sep 9, 2026
Sponsor: National Cancer Institute (NCI)
Renal Pelvis and Ureter Urothelial Carcinoma
United States
Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)Recruiting
NCT07702032Phase 3Updated Sep 9, 2026
Sponsor: Genmab
Left-sided Colorectal Cancer
United States, Puerto Rico
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)Recruiting
NCT05519085Phase 3Updated Sep 9, 2026
Sponsor: Celgene
Relapsed or Refractory Multiple Myeloma
United States, Argentina, Australia, Austria, Belgium +24 more
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes MellitusRecruiting
NCT07662213Phase 3Updated Sep 9, 2026
Sponsor: AstraZeneca
Type 2 Diabetes Mellitus
United States, Argentina, Australia, Brazil, Bulgaria +10 more
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.Recruiting
NCT07753993Phase 3Updated Sep 9, 2026
Sponsor: AstraZeneca
Chronic Kidney Disease
United States, Argentina, Australia, Brazil, Bulgaria +32 more
A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)Recruiting
NCT07541170Phase 3Updated Sep 9, 2026
Sponsor: Hoffmann-La Roche
Non-small Cell Lung Cancer
United States, Argentina, Brazil, Hong Kong, Italy +1 more

Previous page Next page